CELLDEX THERAPEUTICS INC NEW's ticker is CLDX and the CUSIP is 15117B202. A total of 167 filers reported holding CELLDEX THERAPEUTICS INC NEW in Q4 2022. The put-call ratio across all filers is 0.42 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $4,039,407 | -44.5% | 143,700 | -46.7% | 0.03% | -44.3% |
| Q2 2022 | $7,273,754 | +111.5% | 269,798 | +167.3% | 0.06% | +190.5% |
| Q1 2022 | $3,438,357 | -38.6% | 100,950 | -30.4% | 0.02% | -36.4% |
| Q4 2021 | $5,602,800 | +332.4% | 145,000 | +504.2% | 0.03% | +266.7% |
| Q3 2021 | $1,295,760 | -52.6% | 24,000 | -81.9% | 0.01% | -62.5% |
| Q1 2021 | $2,732,323 | +816.9% | 132,637 | +559.9% | 0.02% | +700.0% |
| Q3 2020 | $298,000 | – | 20,100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACUTA CAPITAL PARTNERS, LLC | 1,017,524 | $20,961,000 | 7.56% |
| Octagon Capital Advisors LP | 561,398 | $11,565,000 | 4.36% |
| COMMODORE CAPITAL LP | 369,951 | $7,621,000 | 3.04% |
| Opaleye Management Inc. | 985,000 | $20,291,000 | 2.98% |
| VR Adviser, LLC | 1,240,610 | $25,557,000 | 2.77% |
| TSP Capital Management Group, LLC | 359,229 | $7,400,000 | 2.61% |
| RTW INVESTMENTS, LP | 3,908,947 | $80,524,000 | 1.26% |
| Ghost Tree Capital, LLC | 250,000 | $5,150,000 | 1.21% |
| Tri Locum Partners LP | 196,672 | $4,051,000 | 1.00% |
| Redmile Group, LLC | 3,387,788 | $69,788,000 | 0.98% |